Bausch Health [BHC] vs Alkermes plc [ALKS] Detailed Stock Comparison

Bausch Health

NYSE
Loading...

Alkermes plc

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Bausch Health wins in 7 metrics, Alkermes plc wins in 12 metrics, with 0 ties. Alkermes plc appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricBausch HealthAlkermes plcBetter
P/E Ratio (TTM)25.6915.00Alkermes plc
Price-to-Book Ratio16.853.16Alkermes plc
Debt-to-Equity Ratio14,787.764.47Alkermes plc
PEG Ratio0.02-8.10Alkermes plc
EV/EBITDA7.5210.38Bausch Health
Profit Margin (TTM)0.99%23.15%Alkermes plc
Operating Margin (TTM)18.02%23.80%Alkermes plc
EBITDA Margin (TTM)18.02%23.80%Alkermes plc
Return on Equity14.29%23.94%Alkermes plc
Return on Assets (TTM)4.35%10.49%Alkermes plc
Free Cash Flow (TTM)$1.26B$405.64MBausch Health
1-Year Return-18.62%7.19%Alkermes plc
Price-to-Sales Ratio (TTM)0.253.41Bausch Health
Enterprise Value$23.39B$4.18BBausch Health
EV/Revenue Ratio2.372.78Bausch Health
Gross Profit Margin (TTM)69.80%87.34%Alkermes plc
Revenue per Share (TTM)$27$9Bausch Health
Earnings per Share (Diluted)$0.26$2.07Alkermes plc
Beta (Stock Volatility)0.430.49Bausch Health
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Bausch Health vs Alkermes plc Stock Performance Analysis

Loading Price Chart...

Bausch Health
Alkermes plc
Bausch Health Stock Overview | Alkermes plc Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bausch Health-3.14%0.00%-11.73%-5.82%23.00%-18.51%
Alkermes plc-0.23%6.71%8.93%6.02%5.09%7.79%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bausch Health-18.62%0.31%-62.19%-96.36%-75.78%-71.65%
Alkermes plc7.19%37.00%80.91%-49.47%109.39%93.93%

News Based Sentiment: Bausch Health vs Alkermes plc

Bausch Health

News based Sentiment: MIXED

October saw a blend of positive signals – strong insider buying and market gains – alongside cautious analyst commentary and stock price fluctuations. The upcoming Q3 earnings release on October 29th is a key catalyst that will likely shape the investment narrative going forward, making this a moderately important month for investors.

View Bausch Health News Sentiment Analysis

Alkermes plc

News based Sentiment: MIXED

October presented a mixed bag for Alkermes, with strong financial health and bullish analyst ratings offset by concerning technical signals and underperformance compared to the S&P 500 over longer timeframes. The narrative centers around the upcoming narcolepsy type 2 (NT2) data for alixorexton, which appears to be a key catalyst for the stock, making this a significant month for investors.

View Alkermes plc News Sentiment Analysis

Performance & Financial Health Analysis: Bausch Health vs Alkermes plc

MetricBHCALKS
Market Information
Market Cap i$2.48B$5.26B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i1,482,2701,774,269
90 Day Avg. Volume i1,923,3732,042,650
Last Close$6.47$30.99
52 Week Range$4.25 - $9.85$25.17 - $36.45
% from 52W High-34.31%-14.98%
All-Time High$263.81 (Aug 03, 2015)$98.50 (Feb 28, 2000)
% from All-Time High-97.55%-68.54%
Growth Metrics
Quarterly Revenue Growth0.05%-0.02%
Quarterly Earnings Growth13.80%-0.05%
Financial Health
Profit Margin (TTM) i0.01%0.23%
Operating Margin (TTM) i0.18%0.24%
Return on Equity (TTM) i0.14%0.24%
Debt to Equity (MRQ) i14,787.764.47
Cash & Liquidity
Book Value per Share (MRQ)$-2.07$9.84
Cash per Share (MRQ)$4.67$6.15
Operating Cash Flow (TTM) i$1.51B$521.00M
Levered Free Cash Flow (TTM) i$1.35B$345.67M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Bausch Health vs Alkermes plc

MetricBHCALKS
Price Ratios
P/E Ratio (TTM) i25.6915.00
Forward P/E i1.5115.45
PEG Ratio i0.02-8.10
Price to Sales (TTM) i0.253.41
Price to Book (MRQ) i16.853.16
Market Capitalization
Market Capitalization i$2.48B$5.26B
Enterprise Value i$23.39B$4.18B
Enterprise Value Metrics
Enterprise to Revenue i2.372.78
Enterprise to EBITDA i7.5210.38
Risk & Other Metrics
Beta i0.430.49
Book Value per Share (MRQ) i$-2.07$9.84

Financial Statements Comparison: Bausch Health vs Alkermes plc

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)BHCALKS
Revenue/Sales i$2.53B$306.51M
Cost of Goods Sold i$764.00M$49.20M
Gross Profit i$1.77B$257.31M
Research & Development i$159.00M$71.82M
Operating Income (EBIT) i$457.00M$13.79M
EBITDA i$776.00M$32.91M
Pre-Tax Income i$140.00M$25.49M
Income Tax i$12.00M$3.03M
Net Income (Profit) i$128.00M$22.46M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)BHCALKS
Cash & Equivalents i$1.13B$399.81M
Total Current Assets i$5.73B$1.48B
Total Current Liabilities i$4.26B$443.73M
Long-Term Debt i$21.23B$67.81M
Total Shareholders Equity i$-240.00M$1.51B
Retained Earnings i$-9.88B$-953.99M
Property, Plant & Equipment iN/A$82.41M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)BHCALKS
Operating Cash Flow i$236.00M$122.31M
Capital Expenditures i$-115.00M$-8.40M
Free Cash Flow i$87.00M$88.70M
Debt Repayment i$-168.00M$0
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBHCALKS
Shares Short i7.93M15.06M
Short Ratio i3.197.58
Short % of Float i0.02%0.13%
Average Daily Volume (10 Day) i1,482,2701,774,269
Average Daily Volume (90 Day) i1,923,3732,042,650
Shares Outstanding i367.84M162.18M
Float Shares i225.63M162.42M
% Held by Insiders i0.11%0.01%
% Held by Institutions i0.68%1.05%

Dividend Analysis & Yield Comparison: Bausch Health vs Alkermes plc

MetricBHCALKS
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A